KIORA PHARMACEUTICALS INC Net Cash Provided by (Used in) Financing Activities in USD from 2016 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Kiora Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to Q1 2025.
  • Kiora Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $0.000, a 100% decline year-over-year.
  • Kiora Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $15.5M, a 160% increase from 2023.
  • Kiora Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5.97M, a 30.8% decline from 2022.
  • Kiora Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $8.62M, a 51% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

KIORA PHARMACEUTICALS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $0 -$15.2M -100% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q1 2024 $15.2M +$14.7M +2871% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q1 2023 $513K +$513K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $0 -$8.04M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $8.04M +$3.54M +78.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-07-08
Q1 2020 $4.5M +$4.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 -$1.57K* +$42K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 -$43.6K -$1.87M -102% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $1.82M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11

KIORA PHARMACEUTICALS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $15.5M +$9.53M +160% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-25
2023 $5.97M -$2.65M -30.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-25
2022 $8.62M -$8.96M -51% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 $17.6M +$12.6M +252% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $5M +$1.08M +27.5% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-07-07
2019 $3.92M -$7.38M -65.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $11.3M +$633K +5.94% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-04
2017 $10.7M +$7.17M +205% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
2016 $3.5M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.